Big changes are coming up and the time to act is now, writes Lachlan Ballinger There’s been a lot of confusion – and for good reason. The Pharmacy Business Ownership …

PDL has some advice for avoiding communication lapses when helping patients from varied backgrounds Australia has a rich cultural and linguistic diversity, with over 5.5 million Australians speaking a language …

Pharmacist and technology innovator Robert Sztar has reflected on the impact that various technology disruptors may have on pharmacy When you first hear that disruption and pharmacy make a “perfect …

Earlier this morning, the Peak Strategies team swapped their desks for name badges, coffee cups, and a whole lot of pharmacy talk at one of the highlights of our calendar, …

Business planning is important for any pharmacy owner because it provides a clear direction for a business to follow, Peak Strategies’ practice manager, Victoria Le, writes Like travelling to a …

The PDL Professional Officers have previously provided guidance on detecting forged prescriptions and wish to raise awareness that fraudulent prescriptions continue to be identified in incidents reported to PDL Members …

Why children are uniquely at risk? PDL notes children are involved in almost one-in-10 incident reports it receives Children are not simply small adults; their distinct physiological characteristics, dependence on …

Why the right business structure matters – now and into the future, Peak Strategies’ practice manager, Victoria Le, explains Australia’s small business sector is powered by families, and in pharmacy, …

An election is being held for two PDL directors to serve on the National Board The following vacancies will arise at the conclusion of the next Annual General Meeting, scheduled …

Alan Polack made a real difference in pharmacy education, science and practice, writes Michael Roberts Alan Polack has played a pivotal role as a leader in Australian pharmacy education, science …

In its latest alert, PDL has advice for pharmacists in Queensland with an interest in the newly-extended prescribing scope of practice project Changes were made to the Extended Practice Authority …

Some of the recent changes to the medicines landscape, with new products, indications and contraindications  New Products Canakinumab (rmc) (Ilaris) is a human monoclonal anti-human interleukin (IL)-1beta antibody of the …